Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02400398 · ClinicalTrials.gov registry record
Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients
A clinical trial, sponsored by Andrew Hendifar, MD.
- Completed
- Registry status
- 30
- Enrollment target
NCT02400398 is a clinical trial that has completed, run by Andrew Hendifar, MD. The registered enrollment target is 30 participants.
The verdict
NCT02400398 has completed, sponsored by Andrew Hendifar, MD.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Eligible patients will have a diagnosis of both pancreatic adenocarcinoma and cachexia defined as greater than 5% unintentional weight loss within 6 months prior to screening visit. Patients must be greater than 18 years of age; and have greater than 3 months life expectancy. This study will observe a standard of care intervention (tube feeding) for potential benefit. Peptamen will be administered through a jejunal or a gastrojejunal feeding tube and dosing will be calculated using the Mifflin St. Jeor equation. It will be administered daily for the duration of the protocol.
Interventions
- OTHER Tube feeding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-04-27 |
| Est. Completion | 2020-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02400398
The ClinicalTrials.gov registry entry for NCT02400398 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrew Hendifar, MD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tube feeding is the first listed.
NCT02400398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02400398 about?
NCT02400398 is a clinical study titled "Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients". Eligible patients will have a diagnosis of both pancreatic adenocarcinoma and cachexia defined as greater than 5% unintentional weight loss within 6 months prior to screening visit. Patients must be greater than 18 years of age; and have greater than 3 months life expectancy. This study will observ...
What is the current status of trial NCT02400398?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2015-04-27. Estimated completion is 2020-05-15.
What interventions are being tested in trial NCT02400398?
The interventions under investigation include: Tube feeding (OTHER).
Who is sponsoring clinical trial NCT02400398?
This trial is sponsored by Andrew Hendifar, MD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.